Home > Products > Biosimilars

BioSIM anti-Human HER2 Antibody (Pertuzumab Biosimilar), Research Grade

Catalog: SIM0070
Cost advantage to: SIM0019
Isotype: IgG1-kappa
Product Details Specifications Application References Related Products

Product Details

This non-therapeutic biosimilar uses Pertuzumab’s variable regions, ideal for research. It binds human HER2’s extracellular dimerization domain (HER2: 185 kDa transmembrane proto-oncoprotein, overexpressed in ~40% breast cancers, linked to poor prognosis). Pertuzumab treats HER2-positive metastatic breast cancer by inhibiting HER2 dimerization with other HER receptors, slowing tumor growth.
 

Specifications

Product Name BioSIM anti-Human HER2 Antibody (Pertuzumab Biosimilar), Research Grade
Size 1mg/5mg
Isotype IgG1-kappa
Target HER2
Other Names OMNITARG, rhuMAB2C4, CAS: 380610-27-5
CAS 380610-27-5
Reactivity Human
Host Species Humanized
Background This non-therapeutic biosimilar uses Pertuzumab’s variable regions, ideal for research. It binds human HER2’s extracellular dimerization domain (HER2: 185 kDa transmembrane proto-oncoprotein, overexpressed in ~40% breast cancers, linked to poor prognosis). Pertuzumab treats HER2-positive metastatic breast cancer by inhibiting HER2 dimerization with other HER receptors, slowing tumor growth.
Applications ELISA, FACS, Functional assay, Research in vivo
Purification Protein A/G
Storage To ensure appropriate storage, Please avoid repeated freeze thaw cycles. Keep the product at 4°C for short-term needs (1–2 weeks); Store at -20°C for up to 12 months.  For long-term storage, store at -80°C.
Shipping 2-8°C with blue ice
Concentration Lot specific, generally ≥ 5.0 mg/ml
Shelf Life 12 months from the date of receipt if stored as recommended
Formulation PBS, pH 7.4, contains no stabilizers or preservatives
Sterility 0.2 μM filtered
Endotoxin ≤ 1.0 EU/mg
Purity 99%

Application References

Related Products